Status:
COMPLETED
The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients
Lead Sponsor:
Severance Hospital
Conditions:
Anesthesia Recovery Period, Neuromuscular Blockade
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
To find out the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound rocuronium-induced neuromuscular block in young and elderly adult patients.
Detailed Description
A previous study reported that elderly patients required a longer time to recover from rocuronium induced neuromuscular block compared to younger patients. Therefore, the aim of this study is to find ...
Eligibility Criteria
Inclusion
- 20-40 years or ≥70 years ASA class I-II patients who received surgery less than 2 hours.
Exclusion
- anticipated difficult intubation
- neuromuscular, hepatic or renal disorders
- drug allergy
- body mass index \>30 kg/m2 or body mass index \<18 kg/m2
- emergency surgery
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01890057
Start Date
June 1 2013
End Date
January 1 2014
Last Update
February 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine
Seoul, South Korea